Bausch Health Companies (NYSE:BHC) Issues Earnings Results

Bausch Health Companies (NYSE:BHC) issued its earnings results on Wednesday. The company reported $1.21 EPS for the quarter, missing the consensus estimate of $1.65 by ($0.44), Zacks reports. Bausch Health Companies had a negative return on equity of 755.86% and a negative net margin of 1.88%. Bausch Health Companies updated its FY 2025 guidance to EPS.

Bausch Health Companies Price Performance

Shares of Bausch Health Companies stock traded up $0.18 on Wednesday, reaching $6.54. 2,885,751 shares of the company traded hands, compared to its average volume of 3,337,500. Bausch Health Companies has a 52 week low of $3.96 and a 52 week high of $11.46. The firm has a market capitalization of $2.37 billion, a PE ratio of -13.63, a PEG ratio of 0.32 and a beta of 0.68. The company has a 50 day moving average of $7.39 and a 200 day moving average of $7.47.

Analyst Upgrades and Downgrades

Several analysts recently commented on BHC shares. Royal Bank of Canada cut their target price on shares of Bausch Health Companies from $11.00 to $10.00 and set a “sector perform” rating for the company in a research note on Thursday, January 30th. StockNews.com raised Bausch Health Companies from a “hold” rating to a “buy” rating in a research report on Friday, October 25th. Finally, Jefferies Financial Group reiterated a “hold” rating and issued a $8.00 price objective (down from $12.00) on shares of Bausch Health Companies in a research note on Thursday, February 6th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $7.42.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.